Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.

Wago Corporation: Dedicated signal conditioners

Six new Dedicated Signal Conditioners added to Wago's JUMPFLEX® 857 Series Signal Conditioner and Relay family support focused applications requiring conversion, isolation and/or amplification of just 1 signal type.

Pw 38699 Winmail 00001

To reduce upfront costs and streamline commissioning, the DSCs do not employ an on-unit DIP switch for signal conversion. Panel- and machine-builders utilizing a PLC, VFD or controls with a specific analog input may not require the flexibility of signal configuration. Within these often price-sensitive applications, the DSCs eliminate the need for grafting additional I/O to a PLC or an additional interface card to a VFD.

To ensure safety and reliability, the DIN-rail mount DSCs provide 3-way isolation (2.5kV) and utilize CAGE CLAMP®S Spring Pressure Connection Technology. All DSCs provide a wide extended operating temperature range of -25°C to +70°C. UL/cUL, ULex, CE and GL approved.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report